SecBot SecBot
SC 13G/A ·Filed Oct 30, 2026

PNTG

Pennant Group, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2d 7h ago SEC0002100119-26-001649
Passive stake amendment
Actionable Insight • Neutral

Vanguard's reduction in PNTG stake is a routine portfolio rebalancing by a passive index fund manager. No activist conversion to 13D or control intent is indicated. Monitor next 13F filing for further changes or further reductions below 5%.

DirectionNeutral
Confidencemedium
Horizondays

Price Chart

Loading chart...

Executive Summary

Vanguard Capital Management LLC filed an amended Schedule 13G for Pennant Group, Inc., reporting a 4.97% stake (1,738,970 shares) as of September 30, 2026. This is a decrease from the prior filing, which reported 2,628,650 shares, indicating a reduction of approximately 889,680 shares. The filing remains passive with no activist intent.

Key Financial Metrics

Stake
4.97%
Investor
VANGUARD CAPITAL MANAGEMENT LLC
Investor Type
mutual fund

Key Facts

  • Vanguard Capital Management LLC reported beneficial ownership of 1,738,970 shares of Pennant Group common stock as of September 30, 2026.
  • The stake represents 4.97% of shares outstanding.
  • This is an amendment to a prior Schedule 13G filed July 31, 2026, which reported 2,628,650 shares.
  • The filing explicitly states the securities were acquired and are held in the ordinary course of business, not for changing or influencing control.
  • The filing is made under Rule 13d-1(b) (passive investor).

Financial Impact

Vanguard reduced its stake by approximately 889,680 shares (33.8% decrease) from the prior filing. At the current market cap of $1.5B, the reduction represents roughly $15M-$20M in value.

ownership_percentageshare_count

Risk Factors

  • The filing is a passive 13G amendment with no change in investment intent. The reduction is consistent with index-driven adjustments by a large asset manager.
  • No material risk identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002100119-26-001649
Document: 0002100119-26-001649-index.html0002100119-26-001649
Document: 0002100119-26-001649.txt0002100119-26-001649
12 reports for PNTG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PNTG, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
SC 13G/A
NEUTRAL ★ 3/10
$42.05awaiting T+60awaiting T+60$41.66 (−0.92%)
Sep 16, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$40.03awaiting T+60awaiting T+60$41.66 (+4.07%)
Aug 10, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.64awaiting T+60awaiting T+60$41.66 (+5.10%)
Jul 28, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$42.02awaiting T+60awaiting T+60$41.66 (−0.86%)
Jun 12, 2026
20w ago
Institutional Cluster
BULLISH ★ 5/10
$32.85 $39.31▲ +19.67%▲ +16.40%$41.66 (+26.82%)
Jun 4, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$30.12 $37.08▲ +23.11%▲ +21.23%$41.66 (+38.31%)
May 18, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$34.98 $38.64▲ +10.46%▲ +4.17%$41.66 (+19.10%)
May 14, 2026
24w ago
144
NEUTRAL ★ 2/10
$35.55 $38.17▲ +7.37%▲ +2.85%$41.66 (+17.19%)
May 4, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$31.46 $41.13▲ +30.74%▲ +28.00%$41.66 (+32.42%)
May 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$31.10 $41.08▲ +32.09%▲ +30.23%$41.66 (+33.95%)
Showing 10 of 12

US Market Status

Market Closed · Opens Tue (13h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026